Literature DB >> 30279892

Emergent caesarean section under mechanical circulatory support for acute severe peripartum cardiomyopathy.

Takeshi Mikami1, Hitoshi Kamiunten2.   

Abstract

Peripartum cardiomyopathy (PPCM) is an idiopathic left ventricular dysfunction in women who are in late pregnancy or the postpartum period. PPCM is a rare but sometimes fatal disease, and mechanical circulatory support is required if heart failure is refractory to conventional therapy. A 28-year-old woman in late pregnancy was admitted to our hospital due to congestive heart failure with cardiogenic shock. Her heart rate was 200 beats per minute (sinus tachycardia), and left ventricular ejection fraction (LVEF) was 10%. Additionally, fetal heart rate decreased to 80 beats per minute. It was extremely difficult to continue her pregnancy because of decompensated heart failure and fetal asphyxia; therefore, we delivered her baby via caesarean section after initiating mechanical circulatory support. With optimal medical therapy, including bromocriptine, we were able to remove mechanical circulatory support. Additionally, LVEF improved to 42%, and she was discharged with her baby who had no growth failure. This case highlights the safety and risk of caesarean section under mechanical circulatory support, and the effectiveness of bromocriptine. <Learning objective: Mechanical circulatory support is occasionally required if heart failure is refractory to conventional medical therapy in peripartum cardiomyopathy (PPCM). Mechanical circulatory support, particularly extracorporeal membrane oxygenation needing sufficient anticoagulation, should be initiated following delivery via caesarean section because of bleeding from the uterus. Moreover, bromocriptine may be effective in improving PPCM and should be the first-line treatment in clinical practice.>.

Entities:  

Keywords:  Bromocriptine; Caesarean section; Extracorporeal membrane oxygenation; Intra-aortic balloon counterpulsation; Peripartum cardiomyopathy

Year:  2018        PMID: 30279892      PMCID: PMC6149581          DOI: 10.1016/j.jccase.2018.02.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.

Authors:  U Elkayam; P P Tummala; K Rao; M W Akhter; I S Karaalp; O R Wani; A Hameed; I Gviazda; A Shotan
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine.

Authors:  Denise Hilfiker-Kleiner; Gerd Peter Meyer; Elisabeth Schieffer; Britta Goldmann; Edith Podewski; Ingrid Struman; Philipp Fischer; Helmut Drexler
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

3.  Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.

Authors:  Karen Sliwa; Lori Blauwet; Kemi Tibazarwa; Elena Libhaber; Jan-Peter Smedema; Anthony Becker; John McMurray; Hatice Yamac; Saida Labidi; Ingrid Struman; Ingrid Struhman; Denise Hilfiker-Kleiner
Journal:  Circulation       Date:  2010-03-22       Impact factor: 29.690

4.  Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation.

Authors:  Uri Elkayam; Mohammed W Akhter; Harpreet Singh; Salman Khan; Fahed Bitar; Afshan Hameed; Avraham Shotan
Journal:  Circulation       Date:  2005-04-26       Impact factor: 29.690

5.  Short-term mechanical circulatory support for cardiogenic shock in severe peripartum cardiomyopathy: La Pitié-Salpêtrière experience.

Authors:  Nadia Bouabdallaoui; Pierre Demondion; Pascal Leprince; Guillaume Lebreton
Journal:  Interact Cardiovasc Thorac Surg       Date:  2017-07-01

6.  Recovery from peripartum cardiomyopathy after treatment with bromocriptine.

Authors:  Dirk Habedank; York Kühnle; Thomas Elgeti; Joachim W Dudenhausen; Wilhelm Haverkamp; Rainer Dietz
Journal:  Eur J Heart Fail       Date:  2008-10-15       Impact factor: 15.534

7.  Mechanical circulatory support for patients with peripartum cardiomyopathy.

Authors:  Sabrina Lueck; Juergen Sindermann; Sven Martens; Mirela Scherer
Journal:  J Artif Organs       Date:  2016-03-22       Impact factor: 1.731

8.  Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices.

Authors:  Sofie Gevaert; Yves Van Belleghem; Stefaan Bouchez; Ingrid Herck; Filip De Somer; Yasmina De Block; Fiona Tromp; Els Vandecasteele; Floor Martens; Michel De Pauw
Journal:  Crit Care       Date:  2011-03-10       Impact factor: 9.097

9.  Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.

Authors:  Arash Haghikia; Edith Podewski; Dominik Berliner; Kristina Sonnenschein; Dieter Fischer; Christiane E Angermann; Michael Böhm; Philipp Röntgen; Johann Bauersachs; Denise Hilfiker-Kleiner
Journal:  Clin Res Cardiol       Date:  2015-05-31       Impact factor: 5.460

10.  Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.

Authors:  A Haghikia; E Podewski; E Libhaber; S Labidi; D Fischer; P Roentgen; D Tsikas; J Jordan; R Lichtinghagen; C S von Kaisenberg; I Struman; N Bovy; K Sliwa; J Bauersachs; Denise Hilfiker-Kleiner
Journal:  Basic Res Cardiol       Date:  2013-06-28       Impact factor: 17.165

  10 in total
  3 in total

1.  Extracorporeal Life Support in Pregnancy: A Systematic Review.

Authors:  Emily E Naoum; Andrew Chalupka; Jonathan Haft; Mark MacEachern; Cosmas J M Vandeven; Sarah Rae Easter; Michael Maile; Brian T Bateman; Melissa E Bauer
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

2.  Use of extracorporeal membrane oxygenation in postpartum patients with refractory shock or respiratory failure.

Authors:  Ryoung-Eun Ko; Chi Ryang Chung; Jeong Hoon Yang; Kyeongman Jeon; Gee Young Suh; Soo-Young Oh; Suk-Joo Choi; Ji-Hyuk Yang; Kiick Sung; Yang Hyun Cho
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

3.  Perioperative management of emergent cesarean section in a patient with peripartum cardiomyopathy and orthopnea: a case report.

Authors:  Yuko Kawamoto; Tasuku Nishihara; Jun Aono; Hideyuki Nandate; Taisuke Hamada; Toshiaki Yasuoka; Takashi Matsumoto; Osamu Yamaguchi; Takashi Sugiyama; Toshihiro Yorozuya
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.